CD71 by Immunohistochemistry
Also known as: CD71 IHC
Use
The CD71 by Immunohistochemistry test is used for the detection of CD71 expression in tissue samples. CD71, also known as the transferrin receptor, is a marker of proliferation as it is upregulated in dividing cells. The test aids in the assessment and characterization of various neoplasms where CD71 expression is observed, providing valuable information in the diagnosis and research of cancer.
Special Instructions
Not provided.
Limitations
The CD71 by Immunohistochemistry test is not FDA cleared or approved and was developed and its performance characteristics were determined by ARUP Laboratories in a CLIA-certified laboratory. The results should be interpreted in the context of the entire clinical picture and other diagnostic findings. It is important to note that the specificity and sensitivity of the assay depend on the quality of tissue preparation and adherence to recommended protocols.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
CD71
Protein
LOINC Codes
- 94736-6 - Tissue block ID Spec
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
2 slides
Container
tissue transport kit
Collection Instructions
Formalin fix (10 percent neutral buffered formalin) and paraffin-embed specimen (cells must be prepared into a cellblock). Protect paraffin block and/or slides from excessive heat.
Storage Instructions
Room temperature. Also acceptable: Refrigerated. Ship in cooled container during summer months.
Causes for Rejection
Specimens submitted with nonrepresentative tissue type. Depleted specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant